NCT02751723

Brief Summary

The aim of this non-investigational study is to determine the symptoms and disease burden at the time point of diagnosis and in the further course of an incurable cancer disease. The needs and preferences of patients suffering from cancer (ovarian carcinoma, breast cancer, malignant melanoma, lung cancer, stomach cancer, oesophageal cancer, pancreatic cancer, cancer of the hepatobiliary system, colorectal cancer, head and neck cancer) are examined by various validated questionnaires. The data obtained by these questionnaires are collected together with information obtained by the treating physicians at four time points during the study: t0 - patient´s enrollment, at the moment of diagnosis and before the start of tumor therapy, respectively; T1 - 3 months after patient´s enrollment; T2 - 6 months after patient´s enrollment; T3 - 12 months after patient´s enrollment. This highly innovative project offers the chance to identify medical services deficits and risk circumstances for the burden of treatments in an oncology-palliative setting and to optimize the quality of patient care.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
500

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Sep 2014

Longer than P75 for all trials

Geographic Reach
1 country

21 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2014

Completed
1.6 years until next milestone

First Submitted

Initial submission to the registry

April 14, 2016

Completed
12 days until next milestone

First Posted

Study publicly available on registry

April 26, 2016

Completed
3.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2019

Completed
Last Updated

March 7, 2019

Status Verified

March 1, 2019

Enrollment Period

5.1 years

First QC Date

April 14, 2016

Last Update Submit

March 6, 2019

Conditions

Keywords

cancer diseasepalliative carepalliative therapycancerpatient´s needspatient caredisease burden

Outcome Measures

Primary Outcomes (1)

  • Change from Baseline Patient´s answers regarding symptom burden at 12 months

    12 months after enrollment

Secondary Outcomes (5)

  • Change from Baseline physician´s report at 12 months

    12 months after enrollment

  • Change from Baseline Patient´s answers regarding symptom burden at 6 months

    6 months after enrollment

  • Change from Baseline physician´s report at 6 months

    6 months after enrollment

  • Change from Baseline Patient´s answers regarding symptom burden at 3 months

    3 months after enrollment

  • Change from Baseline physician´s report at 3 months

    3 months after enrollment

Study Arms (10)

lung cancer

validated questionnaires

Other: validated questionnaires

malignant melanoma

validated questionnaires

Other: validated questionnaires

cancer of the hepatobiliary system

validated questionnaires

Other: validated questionnaires

head and neck cancer

validated questionnaires

Other: validated questionnaires

breast cancer

validated questionnaires

Other: validated questionnaires

ovarian carcinoma

validated questionnaires

Other: validated questionnaires

pancreatic cancer

validated questionnaires

Other: validated questionnaires

stomach cancer

validated questionnaires

Other: validated questionnaires

oesophageal cancer

validated questionnaires

Other: validated questionnaires

colorectal cancer

validated questionnaires

Other: validated questionnaires

Interventions

breast cancercancer of the hepatobiliary systemcolorectal cancerhead and neck cancerlung cancermalignant melanomaoesophageal cancerovarian carcinomapancreatic cancerstomach cancer

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

patients with newly diagnosed incurable cancer disease before start of any tumor therapy

You may qualify if:

  • Incurable cancer disease: ovarian carcinoma, breast cancer, malignant melanoma, lung cancer, stomach cancer, oesophageal cancer, pancreatic cancer, cancer of the hepatobiliary system, colorectal cancer, head and neck cancer
  • signed and dated Inform Consent Form
  • Age ≥ 18 years

You may not qualify if:

  • Patient is not able to understand and to answer questions
  • Patient is in a critical health situation and is directly threatened due to cancer disease or the resulting complications

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (21)

UCCL, University of Leipzig

Leipzig, Saxony, 04103, Germany

Location

Municipal Hospital Braunschweig

Braunschweig, Germany

Location

Internal medicine practice

Burgwedel, Germany

Location

Municipal Hospital Essen-Mitte

Essen, Germany

Location

University of Essen

Essen, Germany

Location

University of Göttingen

Göttingen, Germany

Location

University of Hamburg-Eppendorf

Hamburg, Germany

Location

Medical University Hanover

Hanover, Germany

Location

Clinic for Thoraric Diseases (Thoraxklinik)

Heidelberg, Germany

Location

Municipal Hospital Karlsruhe

Karlsruhe, Germany

Location

University of Leipzig, ENT

Leipzig, Germany

Location

Hospital Leverkusen

Leverkusen, Germany

Location

Municipal Hospital Magdeburg

Magdeburg, Germany

Location

University of Mainz

Mainz, Germany

Location

Maria Hilf Clinic

Mönchengladbach, Germany

Location

Radiotherapy practice

Recklinghausen, Germany

Location

University of Regensburg

Regensburg, Germany

Location

Hospital Südstadt Rostock

Rostock, Germany

Location

Immanuel Hospital Rüdersdorf

Rüdersdorf, Germany

Location

Hospital Traunstein

Traunstein, Germany

Location

Comprehensive Cancer Centre Main-Franken

Würzburg, Germany

Location

MeSH Terms

Conditions

Neoplasms

Study Officials

  • Florian Lordick, Prof. Dr.

    University of Leipzig

    STUDY CHAIR
  • Bend Alt-Epping, PD Dr.

    University of Göttingen

    STUDY CHAIR
  • Anja Mehnert, Prof. Dr.

    University of Leipzig

    STUDY CHAIR
  • Birgitt van Oorschot, Prof. Dr.

    Comprehensive Cancer Centre Main-Franken, Würzburg

    STUDY CHAIR
  • Michael Thomas, Prof. Dr.

    Heidelberg University

    STUDY CHAIR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Prof. Dr. med. (MD, PhD)

Study Record Dates

First Submitted

April 14, 2016

First Posted

April 26, 2016

Study Start

September 1, 2014

Primary Completion

October 1, 2019

Study Completion

October 1, 2019

Last Updated

March 7, 2019

Record last verified: 2019-03

Data Sharing

IPD Sharing
Will not share

Locations